Lv1
76 积分 2025-08-10 加入
Anlotinib combined with anti-PD-1 antibody, camrelizumab for advanced NSCLCs after multiple lines treatment: An open-label, dose escalation and expansion study
8个月前
已完结
Molecular mechanisms and cellular functions of cGAS–STING signalling
8个月前
已完结
Regulation of cGAS–STING signalling and its diversity of cellular outcomes
8个月前
已完结
Early detection of colorectal cancer using aberrant circulating cell-free mitochondrial DNA fragmentomics
9个月前
已完结
Glucose metabolism reprogramming in gastric cancer: Implications for tumor
9个月前
已完结
Overcoming resistance to PD-1 inhibitors: the synergistic anti-tumor effect with inflammatory factors
11个月前
已完结
Exploring new frontiers in LAG-3 biology and therapeutics
1年前
已完结
TREM2 and LAG-3 in cancer and Alzheimer's disease immunotherapy
1年前
已完结
Lymphocyte Activation Gene 3 in Inclusion Body Myositis: A Novel Therapeutic Biomarker?
1年前
已完结
Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart
1年前
已完结
Recent development in degradation mechanisms of proton exchange membrane fuel cells for vehicle applications: problems, progress, and perspectives
1年前
已采纳
Biallelic PRMT7 pathogenic variants are associated with a recognizable syndromic neurodevelopmental disorder with short stature, obesity, and craniofacial and digital abnormalities
1年前
已采纳
Recent development in degradation mechanisms of proton exchange membrane fuel cells for vehicle applications: problems, progress, and perspectives
1年前
已撤回
X-Linked Hydrocephalus with New L1CAM Pathogenic Variants: Review of the Most Prevalent Molecular and Phenotypic Features
1年前
已采纳
皖公网安备34019202002308
